|
|
|
|
Department
of Public Health & Preventive Medicine |
Immunisation
|
VACCINATION |
AGE
|
ROUTE
|
|
BCG &
Zero Polio
|
At birth or within 15 days
|
Intra dermal - BCG
Oral - OPV
|
|
DPT , Hep.B & OPV
|
6th week
10th week
14th week
|
Intra muscular –
DPT , Hep.B
Oral – OPV
|
|
MEASLES
|
9th month (after completion of 270 days)
|
Subcutaneous
|
|
DPT booster & OPV
|
16-24 months
|
Intra muscular - DPT
Oral - OPV
|
|
DT
|
5 Year
|
Intra muscular
|
|
TT
|
Preg. Mother - 2 doses
With one month interval.
10 & 16 year Children - 1 dose
|
Intra muscular
|
ACUTE
FLACCID PARALYSIS (AFP) SURVEILLANCE
-
As
part of Polio eradication activities, AFP surveillance is an
important tool to identify all Acute Flaccid Paralysis cases (AFP) in
the age group of <15 years to isolate Polio virus if any and to
confirm non - polio status on each AFP case.
-
Whenever
a child is suffering from fever followed by Acute Flaccid Paralysis,
the child should be admitted to the nearest health facility (
reporting unit ).
-
The
health facility will collect stool specimen from the affected child
and send the specimen to the King Institute laboratory, Chennai for
virological analysis to confirm the diagnosis.
-
On
reporting of each AFP case, one additional dose of OPV is given to
all under 5 years children in the affected village ( area ) as
containment measure.
The
systematic and sustained coverage of routine Immunisation and Pulse
Polio Immunisation leads towards complete eradication of
Poliomyelitis. In the year 2000 and so far in 2001
there have been no cases of Polio. As against 130 cases in 1995.
there have been no cases of Polio in the year 2000, 2001 and till date.
The
incidence of other Vaccine Preventable Diseases is also on
the decline
|
Diseases |
2003 |
2003 |
2004 |
2005
|
2006
|
2007
|
|
CASES |
DEATHS |
CASES |
DEATHS |
CASES |
DEATHS |
CASES |
DEATHS |
CASES
|
DEATHS
|
CASES
|
DEATHS
|
|
Polio |
2 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
4
|
2
|
0
|
0
|
|
Measles |
699 |
4 |
1550 |
3 |
2423 |
1 |
1619 |
1 |
1204
|
0 |
280
|
0 |
|
Diphtheria
|
4 |
2 |
4 |
4 |
1 |
0 |
0 |
0 |
2
|
0
|
1
|
0
|
|
Pertusiss
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0
|
0
|
0
|
0
|
|
Tetanus (Neo) |
2 |
2 |
1 |
1 |
0 |
0 |
0 |
0 |
0
|
0
|
0
|
0
|
|
Tetanus (Other)
|
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0
|
0
|
0
|
0
|
|